In a new study, scientists have reported findings that show a blood test can be used to predict CVD. It may also improve the speed at which new CVD drugs can be identified and developed. If a surrogate can reliably predict risk, then some stages of clinical trials can be streamlined. Finding a surrogate that can accurately predict the risk of certain diseases can also benefit patients directly. Dr. Williams explained to MNT why it has taken so long to realize the FDA’s recommendation.